The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer
Pounds, Rachel Croft, Wayne Pearce, Hayden Hossain, Tasnia Singh, Kavita Balega, Janos Jeevan, David N Sundar, Sudha Kehoe, Sean Yap, Jason
Pounds, Rachel
Croft, Wayne
Pearce, Hayden
Hossain, Tasnia
Singh, Kavita
Balega, Janos
Jeevan, David N
Sundar, Sudha
Kehoe, Sean
Yap, Jason
Citations
Altmetric:
Affiliation
University of Birmingham; Sandwell and West Birmingham NHS Trust; Oxford University Hospitals Foundation Trust
Other Contributors
Publication date
2025-01-06
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Introduction: Ovarian cancer (OC) is the sixth most common malignancy in women and the poor 5-year survival emphasises the need for novel therapies. NK cells play an important role in the control of malignant disease but the nature of tumour-infiltrating and peripheral NK cells in OC remains unclear. Methods: Using flow cytometric analysis, we studied the phenotype and function of NK cells in blood, primary tumour and metastatic tissue in 80 women with OC. The cell type contexture of metastatic OC tissue was explored utilising scRNAseq analysis, with a focus on portraying an immunogenic tumour microenvironment and determining the characteristics of a dysfunctional NK cell population. Results: The proportion of peripheral NK cells was markedly elevated with a highly activated profile and increased cytotoxicity. In contrast, NK cell numbers in primary tumour and metastasis were substantially reduced, with downregulation of activatory receptors together with elevated PD-1 expression. scRNA-Seq identified 5 NK cell subpopulations along with increased exhausted and immature NK cells within tumour tissue compared to normal tissue. These features were attenuated following chemotherapy where higher levels of activated and cytotoxic NK cells associated with improved disease-free survival. Correlation of NK cell phenotype with clinical outcomes revealed high levels of DNAM-1 expression on tissue-localised and peripheral NK cells to be associated with reduced survival. Expression of PVR, the DNAM-1 ligand, was significantly increased on tumours and DNAM-1 mediated NK cell lysis of primary tumour tissue was observed in vitro. Discussion: These findings reveal profound modulation of the tumour tissue and systemic profile of NK cells which likely contributes to the high rates of local progression and metastasis seen with OC. Immunotherapeutic approaches that overcome local immune suppression and enhance DNAM-1-targeted lysis of OC offer the potential to improve disease control.
Citation
Pounds R, Croft W, Pearce H, Hossain T, Singh K, Balega J, Jeevan DN, Sundar S, Kehoe S, Yap J, Moss P, Zuo J. The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer. Front Immunol. 2025 Jan 6;15:1477781. doi: 10.3389/fimmu.2024.1477781
Type
Article